Clinical Trials Related to Hepatocellular Carcinoma

Related studies linked through entity extraction aliases.

The Impact on Survival of Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) Who Underwent Hepatectomy : A Random, Controlled, Stage III Clinical Trial.

Status: RECRUITING
Phase: PHASE3

Metabolic Signature of Healthy Lifestyle and HCC

Status: COMPLETED
Phase: N/A

Clinical Study of ET1402L1-CAR T Cells in AFP Expressing Hepatocellular Carcinoma

Status: TERMINATED
Phase: PHASE1

Evaluation of Gd-EOB-DTPA MRI for Detection and Characterization of Liver Nodules in Cirrhotic Patients Undergoing Liver Transplantation and Potential Impact on Transplant Eligibility

Status: UNKNOWN
Phase: NA

SBRT or TACE for Advanced HCC

Status: UNKNOWN
Phase: PHASE3

Role of LDH as a Predictor of Treatment Outcomes in Hepatocellular Carcinoma

Status: UNKNOWN
Phase: N/A

A Pilot Study to Assess Theragnostically Planned Liver Radiation to Optimize Radiation Therapy

Status: COMPLETED
Phase: NA

Pembrolizumab as Neoadjuvant Treatment in HCC

Status: UNKNOWN
Phase: PHASE2

Comparison of SBRTand Repeat TACE for HCC

Status: UNKNOWN
Phase: NA

TACE Combined With Iodine-125 Seeds Implantation for HCC

Status: UNKNOWN
Phase: NA

FATE-NK100 as Monotherapy and in Combination With Monoclonal Antibody in Subjects With Advanced Solid Tumors

Status: COMPLETED
Phase: PHASE1

A PD Study of Oral eFT508 in Subjects With Advanced TNBC and HCC

Status: TERMINATED
Phase: PHASE2

Study of Pembrolizumab and Radiotherapy in Liver Cancer

Status: TERMINATED
Phase: PHASE2

Study of GNS561 in Patients With Liver Cancer

Status: TERMINATED
Phase: PHASE1/PHASE2

Multicenter RCT of ADV-TK Gene Therapy Improving the Outcome of Liver Transplantation for Advanced HCC

Status: UNKNOWN
Phase: PHASE3

Circulating Cell-free DNA-based Epigenetic Biomarker MSEPT9 for Hepatocellular Carcinoma Detection in Cirrhosis

Status: COMPLETED
Phase: NA

Hepatocellular Carcinoma in Patients With a Cirrhosis Due to an Alcoholic or a Non Alcoholic Fatty Liver Disease

Status: UNKNOWN
Phase: N/A

Hypoxic Changes in Hepatocellular Carcinoma (HCC) Following Trans Arterial Chemo Embolization and Stereotactic Radiation: Fluorine18 (18F) Fluoromisonidazole (FMISO) Imaging

Status: TERMINATED
Phase: PHASE2

Clinical Study of Redirected Autologous T Cells With a Chimeric Antigen Receptor in Patients With Malignant Tumors

Status: UNKNOWN
Phase: NA

Biologic Basis of Liver Cancer From Chronic Hepatitis B

Status: COMPLETED
Phase: N/A